Engineers Gate Manager LP Albireo Pharma, Inc. Transaction History

Engineers Gate Manager LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $878,762 - $1.12 Million	-30,407 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $184,556 - $246,901	-5,762 Reduced 15.93%	30,407 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $255,131 - $340,821	-8,084 Reduced 18.27%	36,169 $1.36 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $1.03 Million - $1.84 Million	44,253 New	44,253 $1.48 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.